The only customers I can possibly see at this point are backyard academic researchers which will NOT bring the returns to holders being voiced.
Other than that, the other option will be the pre-clinical and potentially clinical development route that will take time, money and little return in the short to mid term, meaning the next 2-5 years.
Company has already pointed out that this will be happening.
About to explode, page-3
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.5¢ | 20.0¢ | $6.263K | 30.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 244227 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 140369 | 1 |
View Market Depth
| Last trade - 15.56pm 20/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |